Brainsway Ltd. provides noninvasive neurostimulation treatments for mental health disorders worldwide. Their Deep Transcranial Magnetic Stimulation platform technology targets a range of conditions including major depressive disorders, chronic pain, multiple sclerosis, and autism, among others. Brainsway Ltd. services doctors, hospitals, and medical centers, and was founded in 2003 with its headquarters in Jerusalem, Israel.